Drug Discovery Informatics Market Size, Trends, Analysis, and Outlook By Function (Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, Others), By Application (Drug Discovery, Drug Development), By Solution, Software, Services), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), Others), by Region, Country, Segment, and Companies, 2024-2030
The global Drug Discovery Informatics market size is poised to register 10.92% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Drug Discovery Informatics market across By Function (Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, Others), By Application (Drug Discovery, Drug Development), By Solution, Software, Services), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), Others).
The drug discovery informatics market is experiencing significant growth driven by the increasing adoption of computational tools, artificial intelligence (AI), and big data analytics in pharmaceutical research and development (R&D), the growing emphasis on precision medicine, and the rising demand for novel therapeutics. Drug discovery informatics involves the application of informatics technologies and computational methods to accelerate the drug discovery process, improve target identification, optimize lead compound selection, and enhance preclinical and clinical trial outcomes. Factors such as the expanding drug development pipelines, the need for cost-effective and time-efficient drug discovery solutions, and the integration of data-driven approaches in drug design and optimization are driving market growth. Additionally, advancements in cloud computing, machine learning, and predictive modeling techniques are enabling pharmaceutical companies to harness vast amounts of biological, chemical, and clinical data for more informed decision-making and accelerated drug development cycles. Moreover, the increasing adoption of in silico modeling, virtual screening, and computer-aided drug design (CADD) platforms is revolutionizing the drug discovery process and driving innovation in the pharmaceutical industry. Furthermore, strategic collaborations between pharmaceutical companies, contract research organizations (CROs), and technology providers are fostering the development of integrated informatics solutions and accelerating drug discovery efforts across various therapeutic areas.
Drug Discovery Informatics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Drug Discovery Informatics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Drug Discovery Informatics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Drug Discovery Informatics industry.
Key market trends defining the global Drug Discovery Informatics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Drug Discovery Informatics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Drug Discovery Informatics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Drug Discovery Informatics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Drug Discovery Informatics industry
Leading Drug Discovery Informatics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Drug Discovery Informatics companies.
Drug Discovery Informatics Market Study- Strategic Analysis Review
The Drug Discovery Informatics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Drug Discovery Informatics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Drug Discovery Informatics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Drug Discovery Informatics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Drug Discovery Informatics market segments. Similarly, Strong end-user demand is encouraging Canadian Drug Discovery Informatics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Drug Discovery Informatics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Drug Discovery Informatics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Drug Discovery Informatics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Drug Discovery Informatics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Drug Discovery Informatics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Drug Discovery Informatics in Asia Pacific. In particular, China, India, and South East Asian Drug Discovery Informatics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Drug Discovery Informatics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Drug Discovery Informatics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Drug Discovery Informatics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Drug Discovery Informatics.
Drug Discovery Informatics Market Company Profiles
The global Drug Discovery Informatics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Certara, Boehringer Ingelheim International GmbH, Infosys Ltd, Charles River Laboratories, Collaborative Drug Discovery Inc, Eurofins DiscoverX Products, Jubliant Biosys, Selvita, Novo Informatics Pvt. Ltd, ChemAxon Ltd, Albany Molecular Research Inc, Oracle, Accenture, Agilent Technologies Inc, Illumina Inc
Recent Drug Discovery Informatics Market Developments
The global Drug Discovery Informatics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Drug Discovery Informatics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Function
Sequencing and Target Data Analysis
Docking
Molecular Modelling
Library & Database Preparation
Others
By Application
Drug Discovery
Drug Development
By Solution
Software
Services
By End User
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organization (CROs)
Others
Geographical Segmentation:
Certara
Boehringer Ingelheim International GmbH
Infosys Ltd
Charles River Laboratories
Collaborative Drug Discovery Inc
Eurofins DiscoverX Products
Jubliant Biosys
Selvita
Novo Informatics Pvt. Ltd
ChemAxon Ltd
Albany Molecular Research Inc
Oracle
Accenture
Agilent Technologies Inc
Illumina Inc
Formats Available: Excel, PDF, and PPT
The drug discovery informatics market is experiencing significant growth driven by the increasing adoption of computational tools, artificial intelligence (AI), and big data analytics in pharmaceutical research and development (R&D), the growing emphasis on precision medicine, and the rising demand for novel therapeutics. Drug discovery informatics involves the application of informatics technologies and computational methods to accelerate the drug discovery process, improve target identification, optimize lead compound selection, and enhance preclinical and clinical trial outcomes. Factors such as the expanding drug development pipelines, the need for cost-effective and time-efficient drug discovery solutions, and the integration of data-driven approaches in drug design and optimization are driving market growth. Additionally, advancements in cloud computing, machine learning, and predictive modeling techniques are enabling pharmaceutical companies to harness vast amounts of biological, chemical, and clinical data for more informed decision-making and accelerated drug development cycles. Moreover, the increasing adoption of in silico modeling, virtual screening, and computer-aided drug design (CADD) platforms is revolutionizing the drug discovery process and driving innovation in the pharmaceutical industry. Furthermore, strategic collaborations between pharmaceutical companies, contract research organizations (CROs), and technology providers are fostering the development of integrated informatics solutions and accelerating drug discovery efforts across various therapeutic areas.
Drug Discovery Informatics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Drug Discovery Informatics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Drug Discovery Informatics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Drug Discovery Informatics industry.
Key market trends defining the global Drug Discovery Informatics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Drug Discovery Informatics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Drug Discovery Informatics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Drug Discovery Informatics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Drug Discovery Informatics industry
Leading Drug Discovery Informatics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Drug Discovery Informatics companies.
Drug Discovery Informatics Market Study- Strategic Analysis Review
The Drug Discovery Informatics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Drug Discovery Informatics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Drug Discovery Informatics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Drug Discovery Informatics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Drug Discovery Informatics market segments. Similarly, Strong end-user demand is encouraging Canadian Drug Discovery Informatics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Drug Discovery Informatics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Drug Discovery Informatics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Drug Discovery Informatics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Drug Discovery Informatics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Drug Discovery Informatics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Drug Discovery Informatics in Asia Pacific. In particular, China, India, and South East Asian Drug Discovery Informatics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Drug Discovery Informatics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Drug Discovery Informatics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Drug Discovery Informatics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Drug Discovery Informatics.
Drug Discovery Informatics Market Company Profiles
The global Drug Discovery Informatics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Certara, Boehringer Ingelheim International GmbH, Infosys Ltd, Charles River Laboratories, Collaborative Drug Discovery Inc, Eurofins DiscoverX Products, Jubliant Biosys, Selvita, Novo Informatics Pvt. Ltd, ChemAxon Ltd, Albany Molecular Research Inc, Oracle, Accenture, Agilent Technologies Inc, Illumina Inc
Recent Drug Discovery Informatics Market Developments
The global Drug Discovery Informatics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Drug Discovery Informatics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Function
Sequencing and Target Data Analysis
Docking
Molecular Modelling
Library & Database Preparation
Others
By Application
Drug Discovery
Drug Development
By Solution
Software
Services
By End User
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organization (CROs)
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Certara
Boehringer Ingelheim International GmbH
Infosys Ltd
Charles River Laboratories
Collaborative Drug Discovery Inc
Eurofins DiscoverX Products
Jubliant Biosys
Selvita
Novo Informatics Pvt. Ltd
ChemAxon Ltd
Albany Molecular Research Inc
Oracle
Accenture
Agilent Technologies Inc
Illumina Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Drug Discovery Informatics Market Overview and Key Findings, 2024
1.2 Drug Discovery Informatics Market Size and Growth Outlook, 2021- 2030
1.3 Drug Discovery Informatics Market Growth Opportunities to 2030
1.4 Key Drug Discovery Informatics Market Trends and Challenges
1.4.1 Drug Discovery Informatics Market Drivers and Trends
1.4.2 Drug Discovery Informatics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Drug Discovery Informatics Companies
2. DRUG DISCOVERY INFORMATICS MARKET SIZE OUTLOOK TO 2030
2.1 Drug Discovery Informatics Market Size Outlook, USD Million, 2021- 2030
2.2 Drug Discovery Informatics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. DRUG DISCOVERY INFORMATICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. DRUG DISCOVERY INFORMATICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Function
Sequencing and Target Data Analysis
Docking
Molecular Modelling
Library & Database Preparation
Others
By Application
Drug Discovery
Drug Development
By Solution
Software
Services
By End User
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organization (CROs)
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Drug Discovery Informatics Market, 2025
5.2 Asia Pacific Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Drug Discovery Informatics Market, 2025
5.5 Europe Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.6 Europe Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Drug Discovery Informatics Market, 2025
5.8 North America Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.9 North America Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Drug Discovery Informatics Market, 2025
5.11 South America Pacific Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.12 South America Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Drug Discovery Informatics Market, 2025
5.14 Middle East Africa Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Drug Discovery Informatics Market Size Outlook and Revenue Growth Forecasts
6.2 US Drug Discovery Informatics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Drug Discovery Informatics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Drug Discovery Informatics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Drug Discovery Informatics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Drug Discovery Informatics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Drug Discovery Informatics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Drug Discovery Informatics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Drug Discovery Informatics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Drug Discovery Informatics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Drug Discovery Informatics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Drug Discovery Informatics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Drug Discovery Informatics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Drug Discovery Informatics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Drug Discovery Informatics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Drug Discovery Informatics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Drug Discovery Informatics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Drug Discovery Informatics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Drug Discovery Informatics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Drug Discovery Informatics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Drug Discovery Informatics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Drug Discovery Informatics Industry Drivers and Opportunities
7. DRUG DISCOVERY INFORMATICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. DRUG DISCOVERY INFORMATICS COMPANY PROFILES
8.1 Profiles of Leading Drug Discovery Informatics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Certara
Boehringer Ingelheim International GmbH
Infosys Ltd
Charles River Laboratories
Collaborative Drug Discovery Inc
Eurofins DiscoverX Products
Jubliant Biosys
Selvita
Novo Informatics Pvt. Ltd
ChemAxon Ltd
Albany Molecular Research Inc
Oracle
Accenture
Agilent Technologies Inc
Illumina Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Drug Discovery Informatics Market Overview and Key Findings, 2024
1.2 Drug Discovery Informatics Market Size and Growth Outlook, 2021- 2030
1.3 Drug Discovery Informatics Market Growth Opportunities to 2030
1.4 Key Drug Discovery Informatics Market Trends and Challenges
1.4.1 Drug Discovery Informatics Market Drivers and Trends
1.4.2 Drug Discovery Informatics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Drug Discovery Informatics Companies
2. DRUG DISCOVERY INFORMATICS MARKET SIZE OUTLOOK TO 2030
2.1 Drug Discovery Informatics Market Size Outlook, USD Million, 2021- 2030
2.2 Drug Discovery Informatics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. DRUG DISCOVERY INFORMATICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. DRUG DISCOVERY INFORMATICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Function
Sequencing and Target Data Analysis
Docking
Molecular Modelling
Library & Database Preparation
Others
By Application
Drug Discovery
Drug Development
By Solution
Software
Services
By End User
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organization (CROs)
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Drug Discovery Informatics Market, 2025
5.2 Asia Pacific Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Drug Discovery Informatics Market, 2025
5.5 Europe Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.6 Europe Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Drug Discovery Informatics Market, 2025
5.8 North America Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.9 North America Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Drug Discovery Informatics Market, 2025
5.11 South America Pacific Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.12 South America Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Drug Discovery Informatics Market, 2025
5.14 Middle East Africa Drug Discovery Informatics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Drug Discovery Informatics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Drug Discovery Informatics Market Size Outlook and Revenue Growth Forecasts
6.2 US Drug Discovery Informatics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Drug Discovery Informatics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Drug Discovery Informatics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Drug Discovery Informatics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Drug Discovery Informatics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Drug Discovery Informatics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Drug Discovery Informatics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Drug Discovery Informatics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Drug Discovery Informatics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Drug Discovery Informatics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Drug Discovery Informatics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Drug Discovery Informatics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Drug Discovery Informatics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Drug Discovery Informatics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Drug Discovery Informatics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Drug Discovery Informatics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Drug Discovery Informatics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Drug Discovery Informatics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Drug Discovery Informatics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Drug Discovery Informatics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Drug Discovery Informatics Industry Drivers and Opportunities
7. DRUG DISCOVERY INFORMATICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. DRUG DISCOVERY INFORMATICS COMPANY PROFILES
8.1 Profiles of Leading Drug Discovery Informatics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Certara
Boehringer Ingelheim International GmbH
Infosys Ltd
Charles River Laboratories
Collaborative Drug Discovery Inc
Eurofins DiscoverX Products
Jubliant Biosys
Selvita
Novo Informatics Pvt. Ltd
ChemAxon Ltd
Albany Molecular Research Inc
Oracle
Accenture
Agilent Technologies Inc
Illumina Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
